Showing results (841-850 of 1,036) with videos related to

Sort By:
Pageof 104
Nanoscale|July 5, 2011
PEG-templated mesoporous silica nanoparticles exclusively target cancer cellsCatia Morelli, Pamela Maris, Diego Sisci, et al.
Analytical Chemistry|March 19, 2011
Multifunctional nanoparticles for dual imagingZ Ali, A Z Abbasi, F Zhang, et al.
Nutrients|October 14, 2022
Plant-Based Diets Improve Maternal-Fetal Outcomes in CKD PregnanciesRossella Attini, Filomena Leone, Antoine Chatrenet, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 29, 2024
Reduced TMS-evoked EEG oscillatory activity in cortical motor regions in patients with post-COVID fatigueElias P Casula, Romina Esposito, Sabrina Dezi, et al.
Dalton Transactions (Cambridge, England : 2003)|January 15, 2016
Fluorescent asymmetric bis-ureas for pyrophosphate recognition in pure waterArianna Casula, Carla Bazzicalupi, Alexandre Bettoschi, et al.
Diagnostic Pathology|December 15, 2020
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)Irene Vanni, Milena Casula, Lorenza Pastorino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 13, 2024
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA)Patrizia Tarugi, Stefano Bertolini, Sebastiano Calandra, et al.
Nanomaterials (Basel, Switzerland)|December 22, 2023
In Vitro Antiviral Activity of Hyperbranched Poly-L-Lysine Modified by L-Arginine against Different SARS-CoV-2 VariantsFederico Fiori, Franca Lucia Cossu, Federica Salis, et al.
International Journal of Pharmaceutics|August 6, 2022
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodentMaria Cristina Cardia, Maria Francesca Palmas, Luca Casula, et al.
The Lancet. Respiratory Medicine|April 12, 2021
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 studyLuana Calabrò, Giulia Rossi, Aldo Morra, et al.
Pageof 104